Endoxifen, a Secondary Metabolite of Tamoxifen, and 4-OH-Tamoxifen Induce Similar Changes in Global Gene Expression Patterns in MCF-7 Breast Cancer Cells-Reference-Cited by-同舟云学术

Endoxifen, a Secondary Metabolite of Tamoxifen, and 4-OH-Tamoxifen Induce Similar Changes in Global Gene Expression Patterns in MCF-7 Breast Cancer Cells

Published:2006-05-11 Issue:2 Volume:318 Page:503-512
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Lim Young Chai,Li Lang,Desta Zeruesenay,Zhao Qianqian,Rae James M.,Flockhart David A.,Skaar Todd C.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference40 articles.

1. Tamoxifen Therapy for Breast Cancer and Endometrial Cancer Risk

2. Global analysis of ligand sensitivity of estrogen inducible and suppressible genes in MCF7/BUS breast cancer cells by DNA microarray

Cited by 120 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of CYP2D6 polymorphisms on the efficacy of tamoxifen in Iraqi women with breast cancer;Journal of Contemporary Medical Sciences;2023-12-26

2. Population Pharmacokinetics of Z‐Endoxifen in Patients With Advanced Solid Tumors;The Journal of Clinical Pharmacology;2022-04-19

3. The Potent Phytoestrogen 8-Prenylnaringenin: A Friend or a Foe?;International Journal of Molecular Sciences;2022-03-15

4. Comparative differential cytotoxicity of clinically used SERMs in human cancer lines of different origin and its predictive molecular docking studies of key target genes involved in cancer progression and treatment responses;Current Research in Pharmacology and Drug Discovery;2022

5. Complex interactions of lovastatin with 10 chemotherapeutic drugs: a rigorous evaluation of synergism and antagonism;BMC Cancer;2021-04-06